Navigation Links
Essilor to Acquire 50% of Shamir Optical
Date:10/15/2010

n required Israeli court approval, regulatory and shareholder approvals of the merger and related transactions, and the performance of the obligations pursuant to the related agreements; conflicts in the region, the effects of competition in the industry, and changes in Shamir Optical's or Essilor's relationships with optical laboratories, distributors, research and development partners and other third parties; the effects of the international expansion of operations of Shamir Optical and Essilor, and their ability to manage their growth, including their ability to manage potential future acquisitions; the effect of global economic conditions in general and conditions in the industry and target markets in particular; shifts in supply and demand; market acceptance of new products and continuing products' demand; the impact of competitive products and pricing, including on products and markets; timely product and technology development/upgrades and the ability to manage changes in market conditions as needed; interest rate fluctuations, liquidity and currency risks, and counterparty and investments risks; other operational, market and legal risks; and other factors detailed in Shamir Optical's filings with the Securities and Exchange Commission and in Essilor's annual Registration Document, available on its website (http://www.Essilor.com) (see, in particular, "Risk Factors" in each document). Neither Shamir Optical nor Essilor assume any obligation to update the information in this release.

For more information, please visit http://www.essilor.com. Shamir Optical investor relations and media contacts Jeffrey Goldberger, KCSA Worldwide Managing Director Phone: +1-212-896-1249 (NY) jgoldberger@kcsa.com Essilor investor relations and financial communications Veronique Gillet, SVP Investor Relations Sebastien Leroy, Manager Financial Communications
'/>"/>

SOURCE Essilor
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Essilor : First Half 2009 Revenue
2. Essilor: Essilor Forges New Strategic Partnerships Around the World
3. Essilor : 2009 First Quarter Report
4. Essilor Cancels 1,600,000 Shares
5. Essilor Finalizes Satisloh Agreement
6. Essilors First-Half 2008 Results
7. Essilor : Nomination of Hubert Sagnieres
8. Cell Biosciences to Acquire Convergent Bioscience
9. Met-Pro Corporation Acquires Patented Biological Technology
10. Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company
11. Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015  Neogen Corporation (NASDAQ: NEOG ) announced ... trading plan in accordance with Securities and Exchange Commission ... of Neogen Corporation, is a minority owner of this ... Herbert does not have control of this ... is only for a portion of the shares owned ...
(Date:3/27/2015)... LONDON , March 27, 2015 ... Royal Free Hospital in London , Richmond ... for a global Phase 3 study for an investigational RNAi ... an orphan disease affecting the nerves and heart. ... Record Detail Based at St Georges University ...
(Date:3/27/2015)... 2015 Governor Andrew M. Cuomo today ... 43North - the world’s largest business idea competition with ... of $1 million, six $500,000 awards and four $250,000 ... to compete for prizes that will turn ideas with ... New York region. , "Last year's successful 43North ...
(Date:3/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... including the appointment of auditors, its annual and special ... "Meeting") was adjourned, as previously disclosed on March 25, ... Toronto time). The date of the ... The Meeting will reconvene at the offices of the ...
Breaking Biology Technology:Neogen CEO adopts 10b5-1 Trading Plan 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5SQI Diagnostics Inc. Announces Adjournment of Meeting 2
... 25 Years of Life ... Sciences Industry Experience, RANCHO CORDOVA, Calif., Aug. ... innovative products that,process and store adult stem cells, said today that ... America, has been named to the Company,s Board of,Directors. Her appointment ...
... AEterna Zentaris Inc.,(NASDAQ: AEZS , TSX: AEZ), ... oncology, will announce its second quarter 2008,financial and ... 12,2008. The Company will host a conference call ... day at 4:30 p.m., Eastern Time., Participants ...
... $623 Million; GAAP EPS $0.53; Adjusted EPS $0.48, ... WPI ), a leading specialty pharmaceutical,company, today reported financial ... Second Quarter 2008 Results, Net revenue for the ... $60.3 million, or $0.53 per diluted share. Net income ...
Cached Biology Technology:ThermoGenesis Names Tiffany Olson to Board of Directors 2ThermoGenesis Names Tiffany Olson to Board of Directors 3Watson Pharmaceuticals Reports Second Quarter 2008 Results 2Watson Pharmaceuticals Reports Second Quarter 2008 Results 3Watson Pharmaceuticals Reports Second Quarter 2008 Results 4Watson Pharmaceuticals Reports Second Quarter 2008 Results 5Watson Pharmaceuticals Reports Second Quarter 2008 Results 6Watson Pharmaceuticals Reports Second Quarter 2008 Results 7Watson Pharmaceuticals Reports Second Quarter 2008 Results 8Watson Pharmaceuticals Reports Second Quarter 2008 Results 9Watson Pharmaceuticals Reports Second Quarter 2008 Results 10Watson Pharmaceuticals Reports Second Quarter 2008 Results 11Watson Pharmaceuticals Reports Second Quarter 2008 Results 12Watson Pharmaceuticals Reports Second Quarter 2008 Results 13Watson Pharmaceuticals Reports Second Quarter 2008 Results 14Watson Pharmaceuticals Reports Second Quarter 2008 Results 15Watson Pharmaceuticals Reports Second Quarter 2008 Results 16Watson Pharmaceuticals Reports Second Quarter 2008 Results 17
(Date:3/24/2015)... PALM BEACH GARDENS, Fla. , March 24, ... of biometric identity management solutions, today announced that ... enabling premium clothing accessory retailer Goorin Bros ... login. The Crossmatch biometrics-based solution secures access to ... customers from the increased risk of data breaches. ...
(Date:3/23/2015)... --  HOYOS Labs , a leading global authentication infrastructure ... Company will demonstrate multiple biometrics-based technologies under its identity ... on March 23 through 25, 2015, in ... IEEE Biometric Open Protocol Standard; free biometrics-based consumer app, ... system. BOPS was invented by HOYOS Labs and contributed ...
(Date:3/23/2015)... , Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, announces its biometric ... advertising campaign on CNBC television starting March 30 th ... commence airing in New York markets. ... said: "We are excited about our new ad campaign following ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... Consider that some strains of algae produce toxins ... harmful varieties suck oxygen out of water, suffocating living ... blooms in the Great Lakes, for instance, threaten critical ... and colleagues have figured out how to outsmart the ...
... function!" was the credo of early 20th century architects making ... Cell biologists may be turning that on its head. New ... Standards and Technology (NIST) reinforces the idea that stem cells ... solely by controlling their shape. The results may be important ...
... heart development may also play a part in colon cancer ... Center and the Vanderbilt Eye Institute suggests that the protein ... in regulating corneal cells may be a therapeutic target ... in the October issue of the Journal of Clinical ...
Cached Biology News:Outsmarting algae -- RIT scientist finds the turn-off switch 2Shaping up: Controlling a stem cell's form can determine its fate 2Protein found in heart may be target for colon cancer therapies 2Protein found in heart may be target for colon cancer therapies 3
... Weight Markers, 37 kBq, 1 uCi. Carbon-14 ... of the sample on Western blots.The Rainbow-labeled ... migration in the gel and on the ... without Rainbow-labeling is 0.37-3.7 MBq/mg (10-100 uCi/mg) ...
in vitro Translation, Accessory Products...
... The Zero Blunt TOPO ... Sequencing is designed for ... of blunt-end PCR products. ... 5-minute TOPO Cloning and ...
Request Info...
Biology Products: